Showing results (71-80 of 88) with videos related to
Sort By:
Pageof 9
Carcinogenesis|May 15, 2012
FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repairYun-Yong Park, Sung Yun Jung, Nicholas B Jennings, et al.Molecular Cancer Research : MCR|February 14, 2020
Nucleostemin Modulates Outcomes of Hepatocellular Carcinoma via a Tumor Adaptive Mechanism to Genomic StressJunying Wang, Daniel J McGrail, Parnit K Bhupal, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2026
Axitinib plus Avelumab in Recurrent/Metastatic Adenoid Cystic Carcinoma: Biomarker Analysis and Updated Results of the Phase II TrialCamilla O Hoff, Simon Heeke, Yoshitsugu Mitani, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 28, 2023
Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma-Specific Prognostic RelevanceJuliana Mota Siqueira, Yoshitsugu Mitani, Camilla Oliveira Hoff, et al.Cell Research|January 21, 2015
Tyrosine 370 phosphorylation of ATM positively regulates DNA damage responseHong-Jen Lee, Li Lan, Guang Peng, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2023
Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive TumorsLuana Guimaraes Sousa, Daniel J McGrail, Felippe Lazar Neto, et al.Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|July 8, 2025
TROP2 Expression in Salivary Gland Adenoid Cystic Carcinoma (ACC) According to Histologic Subtype: Therapeutic ImplicationsJuliana Mota Siqueira, Yoshitsugu Mitani, Mario L Marques-Piubelli, et al.Nature Communications|May 3, 2020
PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinomaXian-De Liu, Wen Kong, Christine B Peterson, et al.Cancer Cell|March 14, 2018
BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination DeficiencyChaoyang Sun, Jun Yin, Yong Fang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2020
Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic TargetsRenata Ferrarotto, Yoshitsugu Mitani, Daniel J McGrail, et al.Pageof 9